ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 051,07
0,00%
Dow Jones
43 621,16
0,37%
DAX
22 410,27
-0,05%
Brent Oil
72,745
0,21%
Bitcoin
88 823,21
0,22%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Supernus Pharmaceuticals Inc (SUPN) Cours

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc (SUPN)

NASDAQ
32,81
0,13
(0,40%)
Fermé 26 Février 10:00PM
Retardé de 15 minutes
33,25
0,44
(1,34%)
Après les heures de négociation: 1:39AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
33,25
Prix Achat
33,00
Prix Vente
35,28
Volume échangé
961 794
31,61 Fourchette du Jour 33,50
25,53 Plage de 52 semaines 40,28
Cap du marché
1,836B
Clôture Veille
32,68
Ouverture
32,84
Dernière Transaction
10
@
33.45
Dernière heure de transaction
Volume financier
US$ 30 936 651
VWAP
32,1656
Volume moyen (3 m)
405 699
Actions en circulation
55 219 273
Rendement du Dividende
-
Ratio Cours sur Bénéfices
1 378,99
Bénéfice par action (BPA)
0,02
Chiffre d'affairess
609,04M
Bénéfice net
1,32M

À propos de Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812... Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.supernus.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Supernus Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker SUPN. Le dernier cours de clôture d'Supernus Pharmaceuticals était de US$32,68. Au cours de la dernière année, les actions de Supernus Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 25,53 à US$ 40,28.

Supernus Pharmaceuticals compte actuellement 55 219 273 actions en circulation. La capitalisation boursière d'Supernus Pharmaceuticals est de US$1,80 milliard. Supernus Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de 1378.99.

SUPN Dernières nouvelles

Plus de nouvelles

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
il y a 10 heures
SUPN (0,40%)

Form 8-K - Current report
Edgar (US Regulatory)
il y a 10 heures
SUPN (0,40%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 Février 2025
SUPN (0,40%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 Février 2025
SUPN (0,40%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
25 Février 2025
SUPN (0,40%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Février 2025
SUPN (0,40%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Février 2025
SUPN (0,40%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Février 2025
SUPN (0,40%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-5.84-14.939882322839.0939.9932.4498199634.34843078CS
4-6.14-15.587712617439.3940.2832.4452253236.57008065CS
12-3.35-9.1530054644836.640.2832.4440569936.75948608CS
26-1.93-5.4860716316135.1840.2829.537521035.25260849CS
524.3214.932595921228.9340.2825.5345310232.01170729CS
1561.615.0884955752231.6442.0921.9942453631.9717917CS
2609.238.253638253624.0542.0913.1245815029.02765821CS

SUPN - Frequently Asked Questions (FAQ)

What is the current Supernus Pharmaceuticals share price?
The current share price of Supernus Pharmaceuticals is US$ 33,25
How many Supernus Pharmaceuticals shares are in issue?
Supernus Pharmaceuticals has 55 219 273 shares in issue
What is the market cap of Supernus Pharmaceuticals?
The market capitalisation of Supernus Pharmaceuticals is USD 1,8B
What is the 1 year trading range for Supernus Pharmaceuticals share price?
Supernus Pharmaceuticals has traded in the range of US$ 25,53 to US$ 40,28 during the past year
What is the PE ratio of Supernus Pharmaceuticals?
The price to earnings ratio of Supernus Pharmaceuticals is 1,38k
What is the cash to sales ratio of Supernus Pharmaceuticals?
The cash to sales ratio of Supernus Pharmaceuticals is 2,98
What is the reporting currency for Supernus Pharmaceuticals?
Supernus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Supernus Pharmaceuticals?
The latest annual turnover of Supernus Pharmaceuticals is USD 609,04M
What is the latest annual profit for Supernus Pharmaceuticals?
The latest annual profit of Supernus Pharmaceuticals is USD 1,32M
What is the registered address of Supernus Pharmaceuticals?
The registered address for Supernus Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Supernus Pharmaceuticals website address?
The website address for Supernus Pharmaceuticals is www.supernus.com
Which industry sector does Supernus Pharmaceuticals operate in?
Supernus Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ONVOOrganovo Holdings Inc
US$ 1,2502
(238,81%)
381,24M
RETOReTo Eco Solutions Inc
US$ 1,065
(80,51%)
78,63M
VEROVenus Concept Inc
US$ 0,5402
(76,54%)
15,55M
SLXNSilexion Therapeutics Corporation
US$ 1,23
(64,00%)
87,34M
WAFUWah Fu Education Group Ltd
US$ 2,825
(57,82%)
124,95M
YYAIConnexa Sports Technologies Inc
US$ 0,681
(-46,38%)
6,08M
SNDKSanDisk Corporation
US$ 48,06
(-36,91%)
8,09M
RNAZTransCode Therapeutics Inc
US$ 4,34
(-35,99%)
607,59k
ACONAclarion Inc
US$ 3,25
(-30,26%)
414,95k
BTDRBitdeer Technologies Group
US$ 9,255
(-29,35%)
16,63M
ONVOOrganovo Holdings Inc
US$ 1,2502
(238,81%)
381,24M
NVDANVIDIA Corporation
US$ 126,63
(-2,80%)
267,74M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 14,41
(-16,85%)
166,21M
SMCISuper Micro Computer Inc
US$ 45,54
(-11,76%)
144,34M
TSLATesla Inc
US$ 302,80
(-8,39%)
132,7M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SUPN
Supernus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces